Results 291 to 300 of about 271,169 (372)

T1‐weighted fMRI in mouse visual cortex using an iron oxide nanoparticle contrast agent and UTE imaging at 9.4 T

open access: yesMagnetic Resonance in Medicine, Volume 95, Issue 2, Page 680-692, February 2026.
Abstract Purpose This study aims to investigate the feasibility of using T1‐weighted fMRI with an iron oxide nanoparticle contrast agent and UTE imaging at 9.4 T to measure functional hyperemia in the mouse visual cortex. The goal is to capture positive signal changes in both the parenchyma and pial surface, and to test whether surface vessels respond ...
Naman Jain   +4 more
wiley   +1 more source

Altered functional brain organisation in preterm Children: Motor task and resting-state fMRI findings at six years. [PDF]

open access: yesNeuroimage Clin
Urriola J   +10 more
europepmc   +1 more source

Advancing whole‐brain BOLD functional MRI in humans at 10.5 T with motion‐robust 3D echo‐planar imaging, parallel transmission, and high‐density radiofrequency receive coils

open access: yesMagnetic Resonance in Medicine, Volume 95, Issue 2, Page 1068-1088, February 2026.
Abstract Purpose To demonstrate the feasibility and performance of whole‐brain blood oxygen level–dependent functional MRI (fMRI) in humans at 10.5 T by combining motion‐robust three‐dimensional gradient‐echo echo‐planar imaging, parallel transmission, and high‐density radiofrequency (RF) receive coils.
Shuxian Qu   +15 more
wiley   +1 more source

Specific Brain Activity During Theory of Mind Tasks in Autistic Individuals: A Meta‐Analysis of fMRI Studies

open access: yesPsyCh Journal, Volume 15, Issue 1, February 2026.
ABSTRACT Autistic individuals exhibit differences in Theory of Mind (ToM) compared to neurotypical (NT) individuals. The aim of this study was to meta‐analyse the neural correlates that contributed to the manifestation of the expression differences in ToM between autistic individuals and the NT population.
Hanran Li   +5 more
wiley   +1 more source

Predicting Pharmacological Treatment Response in Migraine Using AI/ML: A Scoping Review of the Evidence and Future Directions

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 2, February 2026.
ABSTRACT The treatment of migraine is hampered by inter‐individual variability, leading to an inefficient “trial and error” approach. Artificial intelligence (AI) and machine learning (ML) offer a path towards precision medicine by predicting therapeutic outcomes.
Martina Giacon, Salvatore Terrazzino
wiley   +1 more source

Home - About - Disclaimer - Privacy